These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 9759748)
1. Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities. Henry K; Melroe H; Huebesch J; Hermundson J; Simpson J Lancet; 1998 Sep; 352(9133):1031-2. PubMed ID: 9759748 [No Abstract] [Full Text] [Related]
2. Atorvastatin versus micronized fenofibrate in the treatment of patients with mixed hyperlipoproteinemia. Milionis HJ; Bairaktari ET; Liberopoulos EN; Elisaf MS Am J Cardiol; 2001 Jul; 88(2):203. PubMed ID: 11463061 [No Abstract] [Full Text] [Related]
4. Rhabdomyolysis after taking atorvastatin with gemfibrozil. Duell PB; Connor WE; Illingworth DR Am J Cardiol; 1998 Feb; 81(3):368-9. PubMed ID: 9468088 [TBL] [Abstract][Full Text] [Related]
5. Predictors of change in low-density lipoprotein size during lipid-lowering treatment in type 2 diabetes. Wägner AM; Ordóñez-Llanos J; Jorba O; Pérez A Metabolism; 2004 Nov; 53(11):1516. PubMed ID: 15558848 [No Abstract] [Full Text] [Related]
6. How to manage metabolic complications of HIV therapy: what to do while we wait for answers. Currier JS AIDS Read; 2000 Mar; 10(3):162-9; discussion 171-4. PubMed ID: 10758016 [TBL] [Abstract][Full Text] [Related]
7. Intervention for hyperlipidemia associated with protease inhibitors. Melroe NH; Kopaczewski J; Henry K; Huebsch J J Assoc Nurses AIDS Care; 1999; 10(4):55-69. PubMed ID: 10394560 [TBL] [Abstract][Full Text] [Related]
8. Statin therapy works for patients who have type 2 diabetes. Korber KE JAAPA; 2008 Oct; 21(10):58, 60. PubMed ID: 19024640 [No Abstract] [Full Text] [Related]
9. Comparative effectiveness of fish oil versus fenofibrate, gemfibrozil, and atorvastatin on lowering triglyceride levels among HIV-infected patients in routine clinical care. Muñoz MA; Liu W; Delaney JA; Brown E; Mugavero MJ; Mathews WC; Napravnik S; Willig JH; Eron JJ; Hunt PW; Kahn JO; Saag MS; Kitahata MM; Crane HM J Acquir Immune Defic Syndr; 2013 Nov; 64(3):254-60. PubMed ID: 23892238 [TBL] [Abstract][Full Text] [Related]
10. Hyperlipoproteinemia affects cytokine production in whole blood samples ex vivo. The influence of lipid-lowering therapy. Mohrschladt MF; Weverling-Rijnsburger AW; de Man FH; Stoeken DJ; Sturk A; Smelt AH; Westendorp RG Atherosclerosis; 2000 Feb; 148(2):413-9. PubMed ID: 10657578 [TBL] [Abstract][Full Text] [Related]
11. The role of lipid management in diabetes. Ganda OP Cardiol Clin; 2005 May; 23(2):153-64, vi. PubMed ID: 15694744 [TBL] [Abstract][Full Text] [Related]
12. Comparison of extended-release niacin and atorvastatin monotherapies and combination treatment of the atherogenic lipid profile in diabetes mellitus. Van JT; Pan J; Wasty T; Chan E; Wu X; Charles MA Am J Cardiol; 2002 Jun; 89(11):1306-8. PubMed ID: 12031735 [No Abstract] [Full Text] [Related]
13. Hyperlipoproteinemias: part IV. Drug regimens. Vogt HB S D J Med; 1991 May; 44(5):117-20. PubMed ID: 1871582 [TBL] [Abstract][Full Text] [Related]
14. Atorvastatin--a new lipid-lowering drug. Med Lett Drugs Ther; 1997 Mar; 39(997):29-31. PubMed ID: 9121394 [No Abstract] [Full Text] [Related]
15. Sexual dysfunction secondary to gemfibrozil. James CW; Wu TS; McNelis KC Pharmacotherapy; 2002 Jan; 22(1):123-5. PubMed ID: 11794424 [TBL] [Abstract][Full Text] [Related]
16. Atorvastatin and amlodipine co-treatment in ASCOT--LLA shows benefit. Cardiovasc J S Afr; 2007; 18(1):43-4. PubMed ID: 17392998 [No Abstract] [Full Text] [Related]
17. Colestimide co-administered with atorvastatin attenuates the progression of vascular calcification in haemodialysis patients. Nitta K; Akiba T; Nihei H Nephrol Dial Transplant; 2004 Aug; 19(8):2156. PubMed ID: 15252184 [No Abstract] [Full Text] [Related]
18. Statin-associated polymyositis following omeprazole treatment. Kanth R; Shah MS; Flores RM Clin Med Res; 2013 Jun; 11(2):91-5. PubMed ID: 23580790 [TBL] [Abstract][Full Text] [Related]
19. Statins in children: what do we know and what do we need to do? Black DM Curr Atheroscler Rep; 2001 Jan; 3(1):29-34. PubMed ID: 11123845 [TBL] [Abstract][Full Text] [Related]
20. Atorvastatin: a new agent for hyperlipidemia. Kupecz D Nurse Pract; 1997 Nov; 22(11):87-8, 90, 93. PubMed ID: 9403876 [No Abstract] [Full Text] [Related] [Next] [New Search]